CompuMed, Inc. Announces Latest Contracts to Provide Remote ECG Screening; Contract Renewals with the GEO Group, Nevada DOC and the City and County of San Francisco Reinforce Company's Dominance in Correctional Facility Market.

LOS ANGELES -- CompuMed, Inc. (OTCBB:CMPD) -- a medical informatics company serving the healthcare community with diagnostic software solutions -- today announced it has renewed agreements to provide electrocardiogram (ECG) remote interpretation systems and services for GEO Group (NYSE:GGI), the Nevada Department of Corrections (NDOC) and the City and County of San Francisco Jail Health Services.

Under the terms of the GEO Group agreement, CompuMed will employ its CardioGram system to provide remote cardiac screening for detainees at the 14 select GEO Group facilities that outsource healthcare services. Based in Boca Raton, Florida, GEO Group is a world leader in privatized correctional and detention services management. Under the terms of the two-year NDOC agreement, CompuMed will continue to provide interpretative ECG services for the correctional system's seven facilities. The five-year City and County of San Francisco contract calls for CompuMed to provide interpretive ECG services for the jurisdiction's six city jails.

"We are delighted to maintain partnerships with these and all of our other correctional facility clients," said Jerry McLaughlin, CompuMed's CEO. "Our solid base of customers clearly recognizes the value-added service that we provide, and this recognition will continue to grow as we work to broaden our offerings in the telemedicine field."

The three contract renewals announced today extend CompuMed's growing dominance as the leading provider of remote ECG screening for the correctional facility market. Over the past two years, the company has announced long-term contracts with statewide correctional departments in several states including New York, California and Nevada. Those contracts involve hundreds of ECG terminals and ongoing remote interpretation services.

CompuMed's traditional core business is providing remote ECG interpretation terminals and related services to medical facilities that may not have access to physicians trained and qualified to interpret ECG results. Customers for the Company's CardioGram system are typically correctional facilities, ambulatory surgery centers, occupational health clinics and physicians' offices. The system reduces healthcare costs significantly by providing remote cardiac screening at the point-of-care. Another advantage is an optional feature that automatically sends ECG results to a trained cardiologist for an overread when the results are abnormal.

About CompuMed

Founded in 1973, CompuMed, Inc. (OTCBB:CMPD) is a leading provider of computer-aided telemedicine and diagnostics technology. The Company's core products are the OsteoGram(R) and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for cost-effective osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. CompuMed is headquartered in Los Angeles. Visit CompuMed at www.compumed.net or call [phone].

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning CompuMed's plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission. All such forward-looking statements are expressly qualified by these cautionary statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.